| Literature DB >> 32508631 |
Xirui He1, Fei Luan2, Yan Yang1, Ze Wang1, Zefeng Zhao3, Jiacheng Fang3, Min Wang1, Manhua Zuo4, Yongsheng Li5.
Abstract
Passiflora edulis, also known as pan> class="Species">passion fruit, is widely distributed in tropical and subtropical areas of the world and becomes popular because of balanced nutrition and health benefits. Currently, more than 110 phytochemical constituents have been found and identified from the different plant parts of P. edulis in which flavonoids and triterpenoids held the biggest share. Various extracts, fruit juice and isolated compounds showed a wide range of health effects and biological activities such as antioxidant, anti-hypertensive, anti-tumor, antidiabetic, hypolipidemic activities, and so forth. Daily consumption of passion fruit at common doses is non-toxic and safe. P. edulis has great potential development and the vast future application for this economically important crop worldwide, and it is in great demand as a fresh product or a formula for food, health care products or medicines. This mini-review aims to provide systematically reorganized information on physiochemical features, nutritional benefits, biological activities, toxicity, and potential applications of leaves, stems, fruits, and peels of P. edulis.Entities:
Keywords: Passiflora edulis; antioxidant activities; nutritional components; passion fruit; polyphenols
Year: 2020 PMID: 32508631 PMCID: PMC7251050 DOI: 10.3389/fphar.2020.00617
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Figure 1Flowers, leaves, and fruits of P. edulis (https://image.baidu.com/).
Nutritional composition of purple and yellow passion fruit juice (USDA Food Composition Databases, 2019).
| Nutrient | Unit | Purple passion fruit juice, raw | Yellow passion fruit juice, raw |
|---|---|---|---|
| Value per 100 g | Value per 100 g | ||
| Proximates | |||
| Water | g | 85.62 | 84.21 |
| Energy | kcal | 51 | 60 |
| Protein | g | 0.39 | 0.67 |
| Total lipid (fat) | g | 0.56 | 0.18 |
| Carbohydrate, by difference | g | 13.6 | 14.45 |
| Fiber, total dietary | g | 0.2 | 0.2 |
| Sugars, total | g | 13.4 | 14.25 |
| Minerals | |||
| Calcium, Ca | mg | 4 | 4 |
| Iron, Fe | mg | 0.24 | 0.36 |
| Magnesium, Mg | mg | 17 | 17 |
| Phosphorus, P | mg | 13 | 25 |
| Potassium, K | mg | 278 | 278 |
| Sodium, Na | mg | 6 | 6 |
| Zinc, Zn | mg | 0.05 | 0.06 |
| Copper, Cu | mg | 0.053 | 0.05 |
| Selenium, Se | µg | 0.1 | 0.1 |
| Vitamins | |||
| Vitamin C, total ascorbic acid | mg | 29.8 | 18.2 |
| Thiamin | mg | 0.000 | 0.000 |
| Riboflavin | mg | 0.131 | 0.101 |
| Niacin | mg | 1.46 | 2.240 |
| Vitamin B-6 | mg | 0.05 | 0.060 |
| Folate, DFE | µg | 7 | 8 |
| Vitamin B-12 | µg | 0.00 | 0.00 |
| Vitamin A, RAE | µg | 36 | 47 |
| Vitamin A, IU | IU | 717 | 943 |
| Vitamin E (alpha-tocopherol) | mg | 0.01 | 0.01 |
| Vitamin D (D2 + D3) | µg | 0.0 | 0.0 |
| Vitamin D | IU | 0 | 0 |
| Vitamin K (phylloquinone) | µg | 0.4 | 0.4 |
| Lipids | |||
| Fatty acids, total saturated | g | 0.004 | 0.015 |
| Fatty acids, total monounsaturated | g | 0.006 | 0.022 |
| Fatty acids, total polyunsaturated | g | 0.029 | 0.106 |
Methods for determination of chemical components of P. edulis.
| Chemical components | Plant part | Location and number of geno-type | Better methods | Major findings | Reference |
|---|---|---|---|---|---|
| Polyphenol | Pulp | Brazil, yellow passion fruit | QuEChERS method combined with C18 as d-SPE clean-up sorbent/UHPLC-MS-MS | Quercetin, rutin, 4-hydroxybenzoic, chlorogenic, ferulic, vanillic, caffeic, |
|
| Volatile compounds | Pulp | Brazil, yellow passion fruit | Dynamic headspace/GC-MS and GC-O analysis | 64 volatile compounds, and mainly include esters, alcohols, terpenes, aldehydes, and ketones, and so forth. |
|
| Carbohydrate | Pulp | France, passion fruit (unknown) | Acid hydrolysis, NaOH (2 M), Fehling solution | 13.70 g glucose equivalent/100 g |
|
| Carotenoid | Pulp | France, passion fruit (unknown) | UV-vis spectrophotometry at 450 nm | 3.83 mg β-carotene equivalent/100 g |
|
| Vitamin C | Pulp | France, passion fruit (unknown) | 2,6-dichloro-phenol-indophenol titrimetric method | 44.40 mg ascorbic acid equivalent/100 g |
|
| Polyphenol | Pulp | France, passion fruit (unknown) | Folin-Ciocalteu assay | 286.60 mg gallic acid equivalent/100 g |
|
| Flavonoid | Pulp | France, passion fruit (unknown) | Colorimetric assay | 70.10 mg quercetin equivalent/100 g |
|
| Polyphenol | Fresh green leaves | Sri Lanka, passion fruit (unknown) | 70% (vol/vol) acetone/alkaline hydrolysis/HPLC | The total soluble, insoluble-bound phenolic compounds and total flavonoid from the extracts were 511.20 mmol/g (gallic acid equivalent), 66.62 mmol/g (gallic acid equivalent), and 111.69 mmol/g (rutin equivalent). |
|
| Polyphenol | Seeds | Brazil, yellow passion fruit | 70% ethanol at 80°C for 30 min | 31.20 mg/g (gallic acid equivalent), and the major component was piceatannol (36.80 mg/g). |
|
| Polyphenol | Peel | Brazil, yellow passion fruit | Ultrasound-assisted or Pressurized solvent extraction (ethanol at 60:40)/LC-DAD-ESI-MS | 4.67 mg/g (gallic acid equivalent). and mainly include orientin, orientin-7- |
|
| Polyphenol | Ripe fruits | Panama, passion fruit (unknown) | Methanol | 81 mg/100 g (Gallic acid equivalent) fresh weight |
|
| Oil | Seeds | Brazil, yellow passion fruit | SE using | High tocopherol and fatty acid like palmitic, stearic, oleic, linoleic, α-Linolenic, behenic, caprylic, and aproic |
|
| Bound terpenoids | Juice | Australia, purple passion fruit | Almond glycosidase hydrolysis with C18 isolates (MeOH elution), HRGC-MS | 15 C13 norterpenoid aglycons, and the main terpenoids are 4-hydroxy-β-ionol, 4-oxo- β -ionol, 4-hydroxy-7,8-dihydro-β-ionol, 4-oxo-7,8-dihydro- β -ionol, 3-oxo-α-ionol, isomeric 3-oxoretro-α-ionols, 3-oxo-7,8-dihydro -α-ionol, 3-hydroxy-1,1, 6-trimethyl-1,2,3, 4-tetrahydronaphthalene, vomifoliol, and dehydrovomifoliol, and so forth. |
|
Chemical Components of P. edulis.
| NO. | Compounds | CAS number | Formula | Resources | Ref. |
|---|---|---|---|---|---|
| 1 | Quercetine | 117-39-5 | C15H10O7 | A |
|
| 2 | Rutin | 153-18-4 | C27H30O16 | A |
|
| 3 | Vitexina | 3681-93-4 | C21H20O10 | A |
|
| 4 | Isoorientin | 4261-42-1 | C21H20O11 | A |
|
| 5 | Saponarin | 20310-89-8 | C27H30O15 | A |
|
| 6 | Homovitexin | 38953-85-4 | C21H20O10 | A |
|
| 7 | Luteolin-6-C-chinovoside | 132368-05-9 | C21 H20 O10 | A |
|
| 8 | Luteolin-6-C-fucoside | 138810-81-8 | C21 H20 O10 | A |
|
| 9 | Orientin | 28608-75-5 | C21 H20 O11 | A |
|
| 10 | Myrtillin | 50986-17-9 | C21 H21 O12+ | A |
|
| 11 | Petunidin 3-glucoside | 71991-88-3 | C22 H23 O12+ | A |
|
| 12 | Cyanidin 3-glucoside | 47705-70-4 | C21 H21 O11+ | A |
|
| 13 | Callistephin | 47684-27-5 | C21 H21 O10+ | A |
|
| 14 | Cyanidin 3-(6″-malonylglucoside) | 171828-62-9 | C24 H23 O14+ | A |
|
| 15 | Pelargonidin 3-(6″-malonylglucoside) | 165070-68-8 | C24 H23 O13+ | A |
|
| 16 | Delphinidin 3-(6″-malonylglucoside) | 478693-96-8 | C24 H23 O15+ | A |
|
| 17 | 1-Benzopyrylium, 3-[[6-O-(carboxyacetyl)-β-D-glucopyranosyl]oxy]-2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy- | 687619-89-2 | C25 H25 O15+ | A |
|
| 18 | Idein | 142506-26-1 | C21 H21 O11+ | A |
|
| 19 | Luteolin | 491-70-3 | C15 H10 O6 | B |
|
| 20 | Lonicerin | 25694-72-8 | C27 H30 O15 | B |
|
| 21 | Vitexin, 4′-rhamnoside | 32426-34-9 | C27 H30 O14 | C |
|
| 22 | Spinosin | 72063-39-9 | C28 H32 O15 | B |
|
| 23 | Vicenin | 23666-13-9 | C27 H30 O15 | B |
|
| 24 | 6,8-di-C-glycosylchrysin | 850621-76-0 | C27 H30 O14 | B |
|
| 25 | Chrysin 6- | 1488426-52-3 | C27 H30 O13 | B |
|
| 26 | Chrysin 7-glucoside | 31025-53-3 | C21 H20 O9 | D |
|
| 27 | 7-[[4- | 378782-33-3 | C27 H30 O13 | D |
|
| 28 | Luteolin 8- | 951126-36-6 | C21 H20 O9 | D |
|
| 29 | 7-De- | 1355022-31-9 | C21 H20 O8 | D |
|
| 30 | 8- | 1355022-34-2 | C21 H20 O8 | D |
|
| 31 | Luteolin 8- | 1402209-61-3 | C27 H30 O14 | D |
|
| 32 | Luteolin 8- | 1402209-62-4 | C21 H20 O9 | D |
|
| 33 | Chrysin-8- | 2171100-31-3 | C27 H30 O13 | E |
|
| 34 | Passiflorin | 1392-82-1 | C37 H60 O12 | A |
|
| 35 | Cyclopassifloic acid E | 301540-74-9 | C31 H52 O8 | D |
|
| 36 | Cyclopassifloic acid F | 301540-76-1 | C31 H52 O7 | D |
|
| 37 | Cyclopassifloic acid G | 301540-77-2 | C31 H52 O7 | D |
|
| 38 | Cyclopassifloside VII | 301540-80-7 | C37 H62 O13 | D |
|
| 39 | Cyclopassifloside VIII | 301540-81-8 | C37 H62 O12 | D |
|
| 40 | Cyclopassifloside X | 301540-82-9 | C37 H62 O12 | D |
|
| 41 | Cyclopassifloside IX | 301644-33-7 | C43 H72 O17 | D |
|
| 42 | Cyclopassifloside XI | 301644-34-8 | C43 H72 O17 | D |
|
| 43 | Passifloric acid | 64147-49-5 | C31 H50 O7 | D |
|
| 44 | Cyclopassifloic acid B | 292167-35-2 | C31 H52 O6 | D |
|
| 45 | Cyclopassifloic acid C | 292167-36-3 | C31 H52 O7 | D |
|
| 46 | Cyclopassifloside IV | 292167-41-0 | C37 H62 O12 | D |
|
| 47 | Cyclopassifloside V | 292167-42-1 | C43 H72 O17 | D |
|
| 48 | Cyclopassifloside VI | 292167-43-2 | C36 H58 O11 | D |
|
| 49 | Cyclopassifloic acid D | 292167-37-4 | C30 H48 O6 | D |
|
| 50 | Cyclopassifloside II | 292167-39-6 | C37 H62 O11 | D |
|
| 51 | Cyclopassifloside I | 292167-38-5 | C37 H62 O12 | D |
|
| 52 | Cyclopassifloside III | 292167-40-9 | C43 H72 O16 | D |
|
| 53 | Cyclopassifloic acid A | 292167-34-1 | C31 H52 O7 | D |
|
| 54 | 3β,16β-diacetoxyurs-12-ene | 920957-33-1 | C34 H54 O4 | F |
|
| 55 | (3β,5α,8α,22 | 2061-64-5 | C28 H44 O3 | C |
|
| 56 | (31 | 1491979-55-5 | C38 H62 O12 | B |
|
| 57 | (31S)-31-O-Methylpassiflorine | 1491979-58-8 | C38 H62 O12 | B |
|
| 58 | (31 | 1492023-84-3 | C37 H60 O12 | B |
|
| 59 | (31S)-Passiflorine | 1492023-87-6 | C37 H60 O12 | B |
|
| 60 | Cyclopassifloside XII | 1595294-85-1 | C37 H60 O12 | D |
|
| 61 | Cyclopassifloside XIII | 1595294-86-2 | C43 H72 O17 | D |
|
| 62 | β-Sitostenone | 1058-61-3 | C29 H48 O | B |
|
| 63 | Harmidine | 304-21-2 | C13 H14 N2 O | A |
|
| 64 | Harmine | 442-51-3 | C13 H12 N2 O | A |
|
| 65 | Harmane | 486-84-0 | C12 H10 N2 | A |
|
| 66 | Harmol | 487-03-6 | C12 H10 N2 O | A |
|
| 67 | 66648-43-9 | C18 H19 N O4 | B |
| |
| 68 | 80510-09-4 | C18 H19 N O4 | B |
| |
| 69 | 3-(Methylthio)-1-hexanol; 3-(Methylthio)hexanol | 51755-66-9 | C7 H16 O S | A |
|
| 70 | 59323-76-1 | C8 H16 O S | A |
| |
| 71 | (±)- | 59324-17-3 | C8 H16 O S | A |
|
| 72 | Ethanethioic acid, S-[1-[2-(acetyloxy)ethyl]butyl] ester | 136954-25-1 | C10 H18 O3 S | A |
|
| 73 | Butanoic acid, 3-[(1-oxobutyl)thio]hexyl ester | 136954-26-2 | C14 H26 O3 S | A |
|
| 74 | Hexanoic acid, 3-[(1-oxohexyl)thio]hexyl ester | 136954-27-3 | C18 H34 O3 S | A |
|
| 75 | Violaxanthin | 126-29-4 | C40 H56 O4 | A |
|
| 76 | β-Cryptoxanthin | 472-70-8 | C40 H56 O | A |
|
| 77 | Neurosporene | 502-64-7 | C40 H58 | A |
|
| 78 | Lycopene | 502-65-8 | C40 H56 | A |
|
| 79 | Mutatochrome | 515-06-0 | C30 H40 O2 | A |
|
| 80 | β-Citraurin | 650-69-1 | C30H40O2 | A |
|
| 81 | Prolycopene | 2361-24-2 | C40 H56 | A |
|
| 82 | β-Carotene | 7235-40-7 | C40 H56 | A |
|
| 83 | Phytoene | 13920-14-4 | C40 H64 | A |
|
| 84 | Neoxanthin | 14660-91-4 | C40 H56 O4 | A |
|
| 85 | Phytofluene | 27664-65-9 | C40 H62 | A |
|
| 86 | Antheraxanthin | 68831-78-7 | C40 H56 O3 | A |
|
| 87 | ζ-Carotene | 72746-33-9 | C40 H60 | A |
|
| 88 | Prunasin | 99-18-3 | C14 H17 N O6 | G |
|
| 89 | Benzyl alcohol | 148031-67-8 | C18 H26 O10 | A |
|
| 90 | 3-Methyl-2-buten-1-yl 6-O-α-L-arabinopyranosyl-β-D-glucopyranoside | 175737-84-5 | C16 H28 O10 | A |
|
| 91 | 1-Ethenyl-1,5-dimethyl-4-hexen-1-yl 6- | 175892-12-3 | C21 H36 O10 | A |
|
| 92 | 3-Oxo-α-ionol | 34318-21-3 | C13 H20 O2 | A |
|
| 93 | Benzoic acid, 2-[[2,3,4-tri- | 191273-45-7 | C32 H40 O18 | A |
|
| 94 | Benzoic acid, 2-[[6- | 191273-46-8 | C20 H28 O12 | A |
|
| 95 | Cyanogenic β-rutinoside | 215583-49-6 | C20 H27 N O10 | A |
|
| 96 | Phenylmethyl β- | 354807-69-5 | C13 H18 O6 | A |
|
| 97 | Passiedulin | 354814-09-8 | C14 H17 N O6 | A |
|
| 98 | Sambunigrin | 99-19-4 | C14 H17 N O6 | A |
|
| 99 | Benzeneacetonitrile, α-(β-D-allopyranosyloxy)-, (αS)- | 474075-97-3 | C14 H17 N O6 | A |
|
| 100 | Passiflactone | 1130942-01-6 | C8 H8 O4 | A |
|
| 101 | Amygdalin | 29883-15-6 | C20 H27 N O11 | B |
|
| 102 | Roseoside | 54835-70-0 | C19 H30 O8 | B |
|
| 103 | 99-96-7 | C7 H6 O3 | B |
| |
| 104 | Vanillic acid | 121-34-6 | C8 H8 O4 | B |
|
| 105 | Syringic acid | 530-57-4 | C9 H10 O5 | B |
|
| 106 | (+)-Syringaresinol | 21453-69-0 | C22 H26 O8 | B |
|
| 107 | 4-Acetyl-3,5-dimethoxy- | 211192-56-2 | C10 H12 O5 | B |
|
| 108 | α-Tocoquinone | 7559-04-8 | C29 H50 O3 | A |
|
| 109 | Prulaurasin | 138-53-4 | C14 H17 N O6 | A |
|
| 110 | Citrusin A | 105279-09-2 | C26 H34 O12 | A |
|
| 111 | Citrusin B | 105279-10-5 | C27 H36 O13 | A |
|
| 112 | Citrusin G | 2173403-45-5 | C28 H38 O12 | A |
|
| 113 | 124151-33-3 | C16 H22 O8 | A |
| |
| 114 | Icariside E5 | 126176-79-2 | C26 H34 O11 | A |
|
| 115 | Alangioside A | 156199-49-4 | C19 H34 O8 | A |
|
| 116 | Longifloroside B | 175556-09-9 | C27 H36 O13 | A |
|
| 117 | Hyuganoside IIIa | 838845-07-1 | C26 H34 O12 | A |
|
| 118 | Hyuganoside IIIb | 838845-08-2 | C26 H34 O12 | A |
|
| 119 | 3,5-Dimethoxy-1-(3-hydroxypropen-1-yl)phenyl 4-O-α-L-rhamnopyranosyl-(1″→6′)-β-D-glucopyranoside | 2171100-32-4 | C23 H34 O13 | A |
|
A: fruits; B: leaves; C: stems; D: leaves and stems; E: peels; F: roots; G: leaves and fruits.
Biological activities of compounds isolated from P. edulis ("↓", reduce; "↑", increase).
| Bioactivity | Compound | Experiment | Biological results | References | |
|---|---|---|---|---|---|
| Positive control | Compound | ||||
| Anti-inflammatory effect | RAW 264.7 cells | IC50 = 34.92 μM, NO production↓ |
| ||
| Luteolin-8- | RAW 264.7 cells | IC50 = 16.12 μM, NO production↓ |
| ||
| Luteolin-8- | RAW 264.7 cells | IC50 = 26.67 μM, NO production ↓ |
| ||
| Isoorientin | Swiss mice | Indomethacin (5 mg/kg), dexamethasone (0.5 mg/kg) | 25 mg/kg ip., leukocytes, neutrophils, mononuclears↓, MPO activity↓ |
| |
| Vicenin-2 | Swiss mice | Indomethacin (5 mg/kg), dexamethasone (0.5 mg/kg) | 25 mg/kg ip., leukocytes, neutrophils, mononuclears↓, MPO activity↓ |
| |
| Spinosin | Swiss mice | Indomethacin (5 mg/kg), dexamethasone (0.5 mg/kg) | 25 mg/kg ip., leukocytes, neutrophils, mononuclears↓, MPO activity↓ |
| |
| Orientin | DMH induced colorectal cancer in rats | 10 mg/kg ip., TNF-α, IL-6, iNOS and COX-2 expression ↓ |
| ||
| Neuroprotective effects | 1α,3β-dihydroxy-16-keto-24(31)-en-cycloartane | PC12 cells | 0.05-0.42 μM against the glutamate-induced neurotoxicity |
| |
| 31-Methoxyl-passifloic acid | PC12 cells | 0.06-0.23 μM against the glutamate-induced neurotoxicity |
| ||
| Cyclopassifloside II | PC12 cells | 0.08-0.35 μM against the glutamate-induced neurotoxicity |
| ||
| Cyclopassifloside VIII | PC12 cells | 0.06-0.46 μM against the glutamate-induced neurotoxicity |
| ||
| Cyclopassifloside XIV | PC12 cells | 0.08-0.32 μM against the glutamate-induced neurotoxicity |
| ||
| Luteolin | PC12 cells | 50.0 μM, NGF-induced neurite outgrowth ↑ |
| ||
| Piceatannol | mouse embryonic stem cells | 2.5 µM, astrocyte differentiation↑ |
| ||
| Anxiolytic-like effect | Isoorientin | Swiss albino mice | Diazepam (2 mg/kg Ig.) | 40 and 80 mg/kg, time spent in open arms of the elevated plus-maze ↑ |
|
| Luteolin-7-O-[2-rhamnosylglucoside] | Swiss mice | Diazepam (1 mg/kg Ig.) | 30 mg/kg, time spent in the open arms of the elevated plus maze test ↑ |
| |
| Antidepressant-like effect | Cyclopassiflosides IX | ICR mice | Clomipramine (50 mg/kg) | 50 mg/kg Ig., immobility time in forced swim and tail suspension test reduced by 22.72% and 39.26% |
|
| Cyclopassiflosides XI | ICR mice | Clomipramine (50 mg/kg) | 50 mg/kg Ig., immobility time in forced swim and tail suspension test reduced by 19.16% and 43.12% |
| |
| Sedative-like activity | Isoorientin | Swiss albino mice | Diazepam (2 mg/kg Ig.) | 40 mg/kg and 80 mg/kg, number of spontaneous activities↓ |
|
| Vasorelaxation effect | Piceatannol | Isolated rat thoracic aorta | 30 μM, eNOS expression↑ |
| |
| Piceatannol | Human EA. hy926 endothelial cells | 20 μM, 48 h, eNOS expression↑ |
| ||
| Scirpusin B | Isolated rat thoracic aorta | 30 μM, endothelium-derived NO↑ |
| ||
| Melanin inhibition and collagen synthesis promotion | Piceatannol | Dermal Cells (SF-TY cells) | 4.5 μM, melanin synthesis↓; 5 μM increased collagen synthesis↑ |
| |
| Isoorientin | B16 melanoma cells | 100 μM, melanin content (47.2% reduction) ↓ |
| ||
| Chrysin 6-C-β-rutinoside | B16 melanoma cells | 100 μM, melanin content (47.2% reduction) ↓, MITF, tyrosinase, TRP-1, and TRP-2 proteins levels ↓ |
| ||
| (6S,9R)-roseoside | B16 melanoma cells | 100 μM, melanin content (37.3% reduction) ↓ |
| ||
| Antidiabetic activity | Piceatannol | db/db mice | 50 mg/kg, blood glucose levels↓ |
| |
| Piceatannol | Humans | 20 mg/day for 56 days, the insulin sensitivity, BP and HR improvement |
| ||
| Antioxidant activity | Scirpusin B | DPPH | Trolox | 5-40 μM, DPPH radical scavenging activities |
|
| Piceatannol | DPPH | Trolox | 5-40 μM, DPPH radical scavenging activities |
| |
| Piceatannol | BALB/cByJ Jcl mice | 10 mg/kg Ig., 14 days, number of astrocytes↑ |
| ||